» Articles » PMID: 38074088

Structure and Computation-guided Yeast Surface Display for the Evolution of TIMP-based Matrix Metalloproteinase Inhibitors

Overview
Specialty Biology
Date 2023 Dec 11
PMID 38074088
Authors
Affiliations
Soon will be listed here.
Abstract

The study of protein-protein interactions (PPIs) and the engineering of protein-based inhibitors often employ two distinct strategies. One approach leverages the power of combinatorial libraries, displaying large ensembles of mutant proteins, for example, on the yeast cell surface, to select binders. Another approach harnesses computational modeling, sifting through an astronomically large number of protein sequences and attempting to predict the impact of mutations on PPI binding energy. Individually, each approach has inherent limitations, but when combined, they generate superior outcomes across diverse protein engineering endeavors. This synergistic integration of approaches aids in identifying novel binders and inhibitors, fine-tuning specificity and affinity for known binding partners, and detailed mapping of binding epitopes. It can also provide insight into the specificity profiles of varied PPIs. Here, we outline strategies for directing the evolution of tissue inhibitors of metalloproteinases (TIMPs), which act as natural inhibitors of matrix metalloproteinases (MMPs). We highlight examples wherein design of combinatorial TIMP libraries using structural and computational insights and screening these libraries of variants using yeast surface display (YSD), has successfully optimized for MMP binding and selectivity, and conferred insight into the PPIs involved.

Citing Articles

Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy.

Shoari A, Ashja Ardalan A, Dimesa A, Coban M Biomolecules. 2025; 15(1).

PMID: 39858430 PMC: 11762759. DOI: 10.3390/biom15010035.


Immunotherapy for locally advanced and metastatic basal cell carcinoma: a narrative review.

Li X, Wang H, Lu Q Transl Cancer Res. 2024; 13(11):6565-6575.

PMID: 39697716 PMC: 11651781. DOI: 10.21037/tcr-24-742.


Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.

Shirian J, Hockla A, Gleba J, Coban M, Rotenberg N, Strik L Biomolecules. 2024; 14(9).

PMID: 39334953 PMC: 11429640. DOI: 10.3390/biom14091187.


Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.

Shirian J, Hockla A, Gleba J, Coban M, Rotenberg N, Strik L bioRxiv. 2024; .

PMID: 38979353 PMC: 11230438. DOI: 10.1101/2024.06.27.600979.

References
1.
Morgunova E, Tuuttila A, Bergmann U, Tryggvason K . Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc Natl Acad Sci U S A. 2002; 99(11):7414-9. PMC: 124245. DOI: 10.1073/pnas.102185399. View

2.
Wilson C, Ouellette A, Satchell D, Ayabe T, Stratman J, Hultgren S . Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science. 1999; 286(5437):113-7. DOI: 10.1126/science.286.5437.113. View

3.
Gomis-Ruth F, Maskos K, Betz M, Bergner A, Huber R, Suzuki K . Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature. 1997; 389(6646):77-81. DOI: 10.1038/37995. View

4.
Lovejoy B, Cleasby A, Hassell A, Longley K, Luther M, Weigl D . Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science. 1994; 263(5145):375-7. DOI: 10.1126/science.8278810. View

5.
Brew K, Nagase H . The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010; 1803(1):55-71. PMC: 2853873. DOI: 10.1016/j.bbamcr.2010.01.003. View